IPO News Archive
Biotech company BioHeart files for IPO

2/13/07


BioHeart, a biotechnology company focused on the discovery, development, and commercialization of therapies using cells derived from a patients body for the treatment of heart damage, filed for an IPO on Tuesday. BMO Capital Markets will be the sole book-running manager on the deal. Terms and timing are yet to be announced.

View IPO Profile: BHRT         
Related Links: Recently Filed IPOs
Source: www.RenaissanceCapital.com
Latest User Comments

Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the IPO Plus Fund (symbol: IPOSX) may have investments in securities of companies mentioned.
Invest in the IPO Plus Fund
About Fund Prospectus Invest